Covid-19 nMAB Infusion service at home

  • NHS Surrey Heartlands ICB

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-018190

Procurement identifier (OCID): ocds-h6vhtk-0468c4

Published 12 June 2024, 2:08pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Surrey Heartlands ICB

Block C, 1st Floor,Dukes Court, Duke Street

WOKING

KT229AE

Contact

Amber Byrne

Email

amber.byrne@nhs.net

Telephone

+44 7585996337

Country

United Kingdom

Region code

UKJ26 - East Surrey

NHS Organisation Data Service

QXU

Internet address(es)

Main address

www.surreyheartlands.org


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Covid-19 nMAB Infusion service at home

Reference number

NMAB001

two.1.2) Main CPV code

  • 85141200 - Services provided by nurses

two.1.3) Type of contract

Services

two.1.4) Short description

This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands in line with NICE TA878.

The contract is required following notice being served since which time patients have been provided with oral antivirals with IV therapy reserved for individuals recommended by their specialist service. IV administration has needed to be delivered at a specialist centre in the absence of an infusion service at home.

The service is required as soon as feasibly possible in the interests of patients.

Surrey Heartlands ICB is intending to follow the Most Suitable Provider Process to award a contract under The Health Care Services (Provider Selection Regime) Regulations 2023.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-015803


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

Following engagement with potential suitable providers for this service, considering the key criteria and applying the basic selection criteria in a fair way across all, the Awarding Authority has decided to halt the Most Suitable Provider process in favour of a Competitive Process which will be launched in the near future.

If at any point in the most suitable provider process the relevant authority has insufficient information to make an assessment under the most suitable provider process, for example, because it did not receive sufficient information to help its decision-making, it is advised to use the competitive process. If the relevant authority fails to identify the most suitable